Summary

Persistence Market Research recently published a comprehensive report on the Fibroblast Growth Factors (FGFs) market, providing in-depth insights into market dynamics, trends, opportunities, and challenges.

Key Insights:

• Fibroblast Growth Factors Market Size (2024E): USD 302.15 million
• Projected Market Value (2033F): USD 582.9 million
• Global Market Growth Rate (CAGR 2024 to 2033): 7.6%

Market Scope:

FGFs play a pivotal role in various medical applications such as wound healing, tissue regeneration, and treating musculoskeletal disorders. These factors stimulate cellular proliferation, angiogenesis, and differentiation, driving therapeutic outcomes across hospitals, clinics, and research institutions. Market growth is fueled by expanding therapeutic applications, advancements in biotechnological manufacturing, and increased research activities.

Market Drivers:

The global FGFs market is propelled by growing investments in regenerative medicine, biotechnology research, and the rising incidence of chronic diseases. Additionally, an aging population susceptible to musculoskeletal disorders and chronic wounds boosts market demand. Technological advancements in recombinant DNA technology and protein engineering contribute to developing novel FGF variants with enhanced therapeutic efficacy.

Market Challenges:

Despite promising growth, the FGFs market faces challenges such as regulatory approval complexities, high development costs, and concerns over long-term safety and efficacy. Stringent regulatory frameworks governing biopharmaceutical manufacturing and clinical trials impose compliance burdens on stakeholders, impacting market dynamics.

Market Opportunities:

The FGFs market offers growth opportunities driven by personalized medicine adoption, expanding applications in wound care and tissue engineering, and strategic collaborations between biopharmaceutical firms and research institutions. Innovations in drug delivery systems, like sustained-release formulations, enhance patient compliance and therapeutic outcomes, fostering market expansion.

Key Questions Answered:

• What are the primary drivers of global FGFs market growth?
• How do therapeutic applications and biotechnological advancements shape market competitiveness?
• Which companies lead the FGFs market, and what strategies sustain their market position?
• What emerging trends and future prospects characterize the global FGFs market?

Competitive Landscape:

Key players including Thermo Fisher Scientific, Merck KGaA (formerly Sigma-Aldrich), PeproTech, and Bio-Techne (R&D Systems) focus on innovation, strategic partnerships, and regulatory compliance. These companies invest in R&D to advance biotechnological platforms, expand therapeutic applications, and enhance market presence through collaborations with academic institutions and healthcare providers.

Key Companies Profiled:

• Thermo Fisher Scientific
• Sigma-Aldrich (now part of Merck KGaA)
• PeproTech
• R&D Systems (a Bio-Techne brand)
• Abcam
• Cell Signaling Technology
• Novus Biologicals

Key Segments of Fibroblast Growth Factors Industry Research

Product:
• FGF1
• FGF2
• FGF3
• FGF4
• FGF7
• FGF10
• FGF11
• FGF12
• FGF13
• FGF14
• FGF15
• FGF18
• FGF19
• FGF20
• FGF23

Application:
• Oncology
• Hematology
• Wound Healing
• Dermatology
• Cardiovascular Disease & Diabetes
• Cell Culture

End User:
• Pharmaceutical & Biotechnology Companies
• Research Centers & Academic Institutes
• CMOs & CDMOs

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Assessment
4.1.1. Product Adoption Analysis
4.1.2. Product USP's/Features Analysis
4.1.3. Recent Product Launches and Innovations
4.1.4. Product Matrix Analysis
4.2. Disease Epidemiology, By Key Countries
4.2.1. Cancer
4.2.2. Acute Wound and Chronic Wound
4.2.3. Parkinson’s Disease
4.3. Regulatory Guidelines
4.4. Porter’s Analysis
4.5. PESTEL Analysis
4.6. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure
5.1.2. Research and Development funding By Region
5.1.3. Global Growth Factor Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Advancements In Manufacturing Technology
5.2.3. Increasing Biopharmaceutical Production
5.2.4. Strategic Collaborations Among Players
5.2.5. Technical Benefits For Manufacturers And Suppliers
5.2.6. Increasing Investments in R&D
5.2.7. Increasing Adoption of Growth Factor in Medical Sciences
5.2.8. Increasing Demand from Growth Factors
5.2.9. Growing Adoption of Tissue Engineering
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Million) Analysis 2019-2023 and Forecast, 2024-2033
6.1. Historical Market Value (US$ Million) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Million) Projections, 2024-2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Product, 2019-2023
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2024-2033
7.3.1. FGF1
7.3.2. FGF2
7.3.3. FGF3
7.3.4. FGF4
7.3.5. FGF7
7.3.6. FGF10
7.3.7. FGF11
7.3.8. FGF12
7.3.9. FGF13
7.3.10. FGF14
7.3.11. FGF15
7.3.12. FGF18
7.3.13. FGF19
7.3.14. FGF20
7.3.15. FGF23
7.3.16. Others
7.4. Market Attractiveness Analysis By Product
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Application, 2019-2023
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2024-2033
8.3.1. Oncology
8.3.2. Hematology
8.3.3. Wound Healing
8.3.4. Dermatology
8.3.5. Cardiovascular Disease & Diabetes
8.3.6. Cell Culture
8.3.7. Others
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By End User, 2019-2023
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2024-2033
9.3.1. Pharmaceutical and Biotechnology Companies
9.3.2. Research Centers & Academic Institutes
9.3.3. CMO and CDMO
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2019-2023
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2024-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (Middle East and Africa)
10.4. Market Attractiveness Analysis, by Region
11. North America Market Analysis 2019-2023 and Forecast 2024-2033
11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
11.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
11.3.1. By Country
11.3.1.1. United States
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Application
11.4.4. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints – Impact Analysis
11.8. Country Level Analysis & Forecast
11.8.1. United States Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast, by Market Taxonomy
11.8.1.2.1. By Product
11.8.1.2.2. By Application
11.8.1.2.3. By End User
11.8.2. Canada Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast, by Market Taxonomy
11.8.2.2.1. By Product
11.8.2.2.2. By Application
11.8.2.2.3. By End User
12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. Brazil Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Application
12.8.1.2.3. By End User
12.8.2. Mexico Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Application
12.8.2.2.3. By End User
12.8.3. Argentina Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast, by Market Taxonomy
12.8.3.2.1. By Product
12.8.3.2.2. By Application
12.8.3.2.3. By End User
13. Europe Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. France
13.3.1.3. Spain
13.3.1.4. Italy
13.3.1.5. BENELUX
13.3.1.6. Russia
13.3.1.7. United Kingdom
13.3.1.8. Rest of Europe
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Germany Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. France Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.2.2.3. By End User
13.8.3. Spain Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Application
13.8.3.2.3. By End User
13.8.4. Italy Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Product
13.8.4.2.2. By Application
13.8.4.2.3. By End User
13.8.5. BENELUX Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Product
13.8.5.2.2. By Application
13.8.5.2.3. By End User
13.8.6. Russia Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Product
13.8.6.2.2. By Application
13.8.6.2.3. By End User
13.8.7. United Kingdom Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Product
13.8.7.2.2. By Application
13.8.7.2.3. By End User
14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. China Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Japan Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. South Korea Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.3.2.3. By End User
15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Thailand
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. India Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Indonesia Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Thailand Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
15.8.4. Malaysia Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Application
15.8.4.2.3. By End User
16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Australia Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. New Zealand Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
17. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Türkiye
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. GCC Countries Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Türkiye Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. Northern Africa Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
17.8.4. South Africa Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Application
17.8.4.2.3. By End User
18. Market Structure Analysis
18.1. Market Analysis, by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Concentration
18.4. Market Presence Analysis
18.4.1. By Regional Footprint of Players
18.4.2. By Product Footprint of Players
18.4.3. By Channel Footprint of Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Key Development Analysis
19.3. Branding and Promotional Strategies by Manufacturers
19.4. Competition Deep Dive
19.4.1. Thermo Fisher Scientific
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Sales Footprint
19.4.1.4. Key Financials
19.4.1.5. SWOT Analysis
19.4.1.6. Key Developments
19.4.1.7. Strategy Overview
19.4.1.7.1. Marketing Strategy
19.4.1.7.2. Product Strategy
19.4.1.7.3. Channel Strategy
19.4.2. Sigma-Aldrich (now part of Merck KGaA)
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Sales Footprint
19.4.2.4. Key Financials
19.4.2.5. SWOT Analysis
19.4.2.6. Key Developments
19.4.2.7. Strategy Overview
19.4.2.7.1. Marketing Strategy
19.4.2.7.2. Product Strategy
19.4.2.7.3. Channel Strategy
19.4.3. PeproTech
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Sales Footprint
19.4.3.4. Key Financials
19.4.3.5. SWOT Analysis
19.4.3.6. Key Developments
19.4.3.7. Strategy Overview
19.4.3.7.1. Marketing Strategy
19.4.3.7.2. Product Strategy
19.4.3.7.3. Channel Strategy
19.4.4. R&D Systems (a Bio-Techne brand)
19.4.4.1. Overview
19.4.4.2. Product Portfolio
19.4.4.3. Sales Footprint
19.4.4.4. Key Financials
19.4.4.5. SWOT Analysis
19.4.4.6. Key Developments
19.4.4.7. Strategy Overview
19.4.4.7.1. Marketing Strategy
19.4.4.7.2. Product Strategy
19.4.4.7.3. Channel Strategy
19.4.5. Abcam
19.4.5.1. Overview
19.4.5.2. Product Portfolio
19.4.5.3. Sales Footprint
19.4.5.4. Key Financials
19.4.5.5. SWOT Analysis
19.4.5.6. Key Developments
19.4.5.7. Strategy Overview
19.4.5.7.1. Marketing Strategy
19.4.5.7.2. Product Strategy
19.4.5.7.3. Channel Strategy
19.4.6. Cell Signaling Technology
19.4.6.1. Overview
19.4.6.2. Product Portfolio
19.4.6.3. Sales Footprint
19.4.6.4. Key Financials
19.4.6.5. SWOT Analysis
19.4.6.6. Key Developments
19.4.6.7. Strategy Overview
19.4.6.7.1. Marketing Strategy
19.4.6.7.2. Product Strategy
19.4.6.7.3. Channel Strategy
19.4.7. Novus Biologicals
19.4.7.1. Overview
19.4.7.2. Product Portfolio
19.4.7.3. Sales Footprint
19.4.7.4. Key Financials
19.4.7.5. SWOT Analysis
19.4.7.6. Key Developments
19.4.7.7. Strategy Overview
19.4.7.7.1. Marketing Strategy
19.4.7.7.2. Product Strategy
19.4.7.7.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology